IL5 and infection: The following stimulant–cytokine combinations were associated with risk of infection in the following 3-month period with p < 0.05 on univariate analysis: unstimulated-IL5 at EOI was associated with reduced risk of infection while increased risk was seen with PMA-IL3 and PMA-IL5 in maintenance samples.